• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    OncoGenex Pharmaceuticals, Inc. (OGXI)

    -NasdaqCM
    2.01 Down 0.01(0.50%) Jan 30, 4:00PM EST
    Add to Portfolio
    Prev Close:2.02
    Open:1.98
    Bid:N/A
    Ask:2.36 x 2000
    1y Target Est:6.85
    Beta:0.66
    Earnings Date:Mar 9 - Mar 13 (Est.)
    Day's Range:1.98 - 2.03
    52wk Range:1.95 - 14.25
    Volume:86,879
    Avg Vol (3m):293,534
    Market Cap:42.77M
    P/E (ttm):N/A
    EPS (ttm):-1.66
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OGXI

    Comparison

    Symbol% ChgMkt Cap
    OGXIDown 0.50%42.77M
    BMYDown 1.42%99.97B
    CELGDown 1.41%95.17B
    PFEDown 1.82%196.90B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1.43
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.45
    Quarterly EPS Est (Dec-14) :-0.30
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback